$7.74
3.07% today
Nasdaq, Oct 13, 04:25 pm CET
ISIN
US67092M2089
Symbol
NTRB

Nutriband Stock price

$7.51
+1.51 25.17% 1M
+3.73 98.89% 6M
+3.74 99.31% YTD
+1.83 32.22% 1Y
+4.45 145.75% 3Y
+2.37 46.03% 5Y
+2.98 65.94% 10Y
+2.98 65.94% 20Y
Nasdaq, Closing price Fri, Oct 10 2025
-0.40 5.06%
ISIN
US67092M2089
Symbol
NTRB
Industry

Key metrics

Basic
Market capitalization
$90.4m
Enterprise Value
$83.6m
Net debt
positive
Cash
$7.0m
Shares outstanding
12.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
35.0 | 6.4
EV/Sales
32.4 | 5.9
EV/FCF
negative
P/B
10.7
Financial Health
Equity Ratio
86.1%
Return on Equity
-163.1%
ROCE
-79.1%
ROIC
-384.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.6m | $14.1m
EBITDA
$-6.6m | -
EBIT
$-6.8m | $-7.7m
Net Income
$-32.1m | $-6.9m
Free Cash Flow
$-5.0m
Growth (TTM | estimate)
Revenue
43.3% | 560.6%
EBITDA
-8.3% | -
EBIT
-7.6% | -14.7%
Net Income
-343.1% | 34.5%
Free Cash Flow
-16.5%
Margin (TTM | estimate)
Gross
34.4%
EBITDA
-253.9% | -
EBIT
-264.0%
Net
-1,244.4% | -48.6%
Free Cash Flow
-192.1%
More
EPS
$-2.9
FCF per Share
$-0.4
Short interest
2.1%
Employees
13
Rev per Employee
$160.0k
Show more

Is Nutriband a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.

Nutriband Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nutriband forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nutriband forecast:

Buy
86%
Hold
14%

Financial data from Nutriband

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '25
+/-
%
2.58 2.58
43% 43%
100%
- Direct Costs 1.69 1.69
41% 41%
66%
0.89 0.89
46% 46%
34%
- Selling and Administrative Expenses 5.08 5.08
25% 25%
197%
- Research and Development Expense 2.62 2.62
8% 8%
102%
-6.55 -6.55
8% 8%
-254%
- Depreciation and Amortization 0.26 0.26
7% 7%
10%
EBIT (Operating Income) EBIT -6.81 -6.81
8% 8%
-264%
Net Profit -32 -32
343% 343%
-1,243%

In millions USD.

Don't miss a Thing! We will send you all news about Nutriband directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nutriband Stock News

Neutral
GlobeNewsWire
3 days ago
Nutriband initiates commercial worldwide brand name development for its lead product, an abuse deterrent transdermal system. Nutriband has partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development.
Neutral
GlobeNewsWire
5 days ago
Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing  opioids and stimulants with a potential for abuse. Nutriband's AVERSA™ abuse-deterrent technology consists of a proprietary aversive agent coating that employs taste aversion to deter oral abuse and reduce accidental exposure.
Neutral
GlobeNewsWire
5 days ago
ORLANDO, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman Serguei Melnik will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on Wednesday, October 8 at 15:00 Eastern Standard Time.
More Nutriband News

Company Profile

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2016 and is headquartered in Orlando, FL.

Head office United States
CEO Gareth Sheridan
Employees 13
Founded 2012
Website nutriband.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today